Free Trial
→ Why Elon put $51 million into this (From True Market Insiders) (Ad) Buy DOC Stock  Free DOC Stock Alerts

Healthpeak Properties (DOC) Financials

Healthpeak Properties logo
$17.44 -0.14 (-0.77%)
Closing price 03:59 PM Eastern
Extended Trading
$17.62 +0.18 (+1.03%)
As of 06:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Healthpeak Properties

Annual Income Statements for Healthpeak Properties

This table shows Healthpeak Properties' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 -561 627 413 1,058 44 411 502 498 304 242
Consolidated Net Income / (Loss)		 -546 640 423 1,073 60 428 526 516 335 267
Net Income / (Loss) Continuing Operations		 153 374 423 837 175 161 138 514 335 267
Total Pre-Tax Income 		136 367 410 839 176 218 128 507 315 273
Total Revenue		 1,461 1,665 1,541 930 1,023 1,427 1,738 1,888 1,981 2,420
Net Interest Income / (Expense)		 -367 -376 -251 -251 -208 -202 -120 -150 -179 -236
Total Interest Income		 112 89 56 10 9.84 17 38 23 22 45
Investment Securities Interest Income		 112 89 56 10 9.84 17 38 23 22 45
Total Interest Expense		 480 464 308 261 218 218 158 173 200 280
Long-Term Debt Interest Expense		 480 464 308 261 218 218 158 173 200 280
Total Non-Interest Income		 1,828 2,040 1,792 1,181 1,230 1,628 1,858 2,038 2,159 2,656
Service Charges on Deposit Accounts		 525 - 524 144 144 436 471 495 527 568
Other Non-Interest Income		 1,303 2,040 1,268 1,037 1,086 1,192 1,387 1,543 1,632 2,087
Total Non-Interest Expense		 1,347 1,420 1,464 892 953 1,491 1,581 1,716 1,759 2,385
Other Operating Expenses		 707 842 755 475 498 876 872 994 997 1,172
Depreciation Expense		 505 568 535 405 435 554 684 711 750 1,057
Impairment Charge		 108 0.00 166 11 18 43 23 7.00 -5.60 23
Restructuring Charge		 27 9.82 7.96 1.14 1.96 18 1.84 4.85 18 133
Nonoperating Income / (Expense), net		 23 122 334 801 107 282 -29 335 93 238
Income Tax Expense		 -9.81 4.47 -1.33 -4.40 -5.48 -9.42 -3.26 -4.43 -9.62 4.35
Other Gains / (Losses), net		 6.59 11 11 -5.76 -6.33 -67 6.10 1.99 10 -1.52
Net Income / (Loss) Discontinued Operations		 -699 266 - 236 -115 268 388 2.88 0.00 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest		 13 12 8.47 12 15 14 21 19 30 25
Basic Earnings per Share		 ($1.21) $1.34 $0.88 $2.25 $0.09 $0.77 $0.93 $0.92 $0.56 $0.36
Weighted Average Basic Shares Outstanding		 462.80M 467.20M 468.76M 470.55M 486.26M 530.56M 538.93M 538.81M 547.01M 675.68M
Diluted Earnings per Share		 ($1.21) $1.34 $0.88 $2.24 $0.09 $0.77 $0.93 $0.92 $0.56 $0.36
Weighted Average Diluted Shares Outstanding		 462.80M 467.40M 468.94M 475.39M 489.34M 531.06M 539.24M 539.15M 547.28M 676.23M
Weighted Average Basic & Diluted Shares Outstanding		 463.30M 467.60M 469.30M 470.40M 505.41M 538.69M 539.30M 546.78M 547.17M 699.56M
Cash Dividends to Common per Share		 $2.26 $2.10 $1.48 $1.48 $1.48 $1.48 $1.20 $1.20 $1.20 $1.20

Quarterly Income Statements for Healthpeak Properties

This table shows Healthpeak Properties' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 353 6.73 118 52 64 71 6.48 146 86 4.40 42
Consolidated Net Income / (Loss)		 358 11 135 56 69 75 11 153 93 11 50
Net Income / (Loss) Continuing Operations		 359 9.93 135 56 69 75 11 153 93 11 50
Total Pre-Tax Income 		356 9.44 133 55 67 60 22 155 99 -3.23 54
Total Revenue		 476 475 478 496 506 501 546 621 626 627 630
Net Interest Income / (Expense)		 -38 -43 -42 -44 -45 -48 -55 -67 -60 -54 -57
Total Interest Income		 5.96 6.35 6.16 5.28 5.36 4.98 5.75 7.83 14 17 16
Investment Securities Interest Income		 5.96 6.35 6.16 5.28 5.36 4.98 5.75 7.83 14 17 16
Total Interest Expense		 44 49 48 49 51 53 61 75 74 71 73
Long-Term Debt Interest Expense		 44 49 48 49 51 53 61 75 74 71 73
Total Non-Interest Income		 514 518 520 540 551 549 601 688 686 681 687
Service Charges on Deposit Accounts		 122 126 127 130 134 136 139 141 143 146 149
Other Non-Interest Income		 392 392 392 410 417 412 462 547 543 535 538
Total Non-Interest Expense		 422 464 427 449 440 443 605 591 591 598 570
Other Operating Expenses		 245 278 248 248 256 246 267 301 303 301 299
Depreciation Expense		 173 179 179 198 185 189 219 283 280 274 269
Impairment Charge		 3.41 3.33 -2.21 2.61 -0.55 -5.45 11 -0.55 0.44 12 -3.56
Restructuring Charge		 0.73 3.22 2.43 0.64 0.04 14 107 7.76 7.13 11 5.53
Nonoperating Income / (Expense), net		 302 -1.56 82 6.84 1.48 2.60 82 126 63 -33 -6.13
Income Tax Expense		 -3.83 -0.65 0.30 1.14 0.79 -12 14 2.73 1.94 -14 2.08
Other Gains / (Losses), net		 -0.33 -0.16 1.82 2.73 2.10 3.56 2.38 0.05 -3.83 -0.11 -2.15
Net Income / (Loss) Attributable to Noncontrolling Interest		 4.62 6.33 17 4.45 4.61 4.61 4.70 6.88 7.06 6.27 7.70
Basic Earnings per Share		 $0.66 - $0.22 $0.09 $0.12 $0.13 $0.01 $0.21 $0.12 $0.02 $0.06
Weighted Average Basic Shares Outstanding		 538.42M 538.81M 546.84M 547.03M 547.06M 547.01M 600.90M 702.38M 699.35M 675.68M 699.07M
Diluted Earnings per Share		 $0.65 $0.01 $0.22 $0.09 $0.12 $0.13 $0.01 $0.21 $0.12 $0.02 $0.06
Weighted Average Diluted Shares Outstanding		 546.02M 539.15M 547.11M 547.29M 547.33M 547.28M 601.19M 703.27M 700.15M 676.23M 699.12M
Weighted Average Basic & Diluted Shares Outstanding		 537.54M 546.78M 547.00M 547.05M 547.07M 547.17M 703.78M 699.29M 699.44M 699.56M 694.73M
Cash Dividends to Common per Share		 $0.30 $0.30 $0.30 $0.30 $0.30 $0.30 $0.30 $0.30 $0.30 $0.30 $0.31

Annual Cash Flow Statements for Healthpeak Properties

This table details how cash moves in and out of Healthpeak Properties' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 174 -270 -55 58 45 -2.97 38 -93 42 15
Net Cash From Operating Activities		 1,222 1,214 847 849 846 758 795 900 956 1,070
Net Cash From Continuing Operating Activities		 1,228 1,214 847 849 846 758 795 900 956 1,070
Net Income / (Loss) Continuing Operations		 -546 640 423 1,073 60 428 526 516 335 267
Consolidated Net Income / (Loss)		 -546 640 423 1,073 60 428 526 516 335 267
Depreciation Expense		 511 573 535 549 660 697 684 711 750 1,057
Amortization Expense		 20 20 15 13 11 -72 -85 -92 -97 -91
Non-Cash Adjustments to Reconcile Net Income		 1,296 -54 -105 -833 93 -404 -356 -354 -114 -208
Changes in Operating Assets and Liabilities, net		 -53 35 -20 46 22 109 26 119 83 45
Net Cash From Investing Activities		 -1,660 -429 1,246 1,829 -1,449 -1,008 531 -876 -577 -114
Net Cash From Continuing Investing Activities		 -1,660 -429 1,246 1,829 -1,449 -1,008 531 -876 -577 -114
Purchase of Property, Leasehold Improvements and Equipment		 -84 -91 -115 -106 -109 -94 -111 -109 -114 -116
Purchase of Investment Securities		 -2,308 -1,246 -1,011 -587 -2,326 -2,441 -2,137 -1,072 -855 -592
Sale and/or Maturity of Investments		 628 232 2,335 2,528 514 1,509 2,742 291 371 751
Other Investing Activities, net		 31 28 37 26 382 19 38 13 21 -156
Net Cash From Financing Activities		 614 -1,054 -2,148 -2,621 647 246 -1,289 -117 -337 -941
Net Cash From Continuing Financing Activities		 614 -1,054 -2,148 -2,621 647 246 -1,289 -117 -337 -941
Issuance of Debt		 2,368 2,794 1,250 2,047 9,905 5,337 17,910 16,382 11,088 4,491
Issuance of Common Equity		 206 68 28 517 796 1,069 5.04 308 0.28 0.32
Repayment of Debt		 -989 -2,912 -2,670 -4,401 -9,332 -5,322 -18,448 -16,062 -10,718 -4,358
Repurchase of Common Equity		 -8.74 -8.69 -4.79 -3.43 -5.04 -11 -13 -68 -6.52 -191
Payment of Dividends		 -1,047 -980 -695 -697 -720 -787 -650 -648 -657 -795
Other Financing Activities, Net		 85 -16 -56 -83 3.80 -41 -93 -29 -45 -90

Quarterly Cash Flow Statements for Healthpeak Properties

This table details how cash moves in and out of Healthpeak Properties' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Change in Cash & Equivalents		 33 -42 -9.61 43 -47 55 -12 2.14 83 -58 -46
Net Cash From Operating Activities		 244 207 174 298 253 231 153 316 318 284 279
Net Cash From Continuing Operating Activities		 244 207 174 298 253 231 153 316 318 284 279
Net Income / (Loss) Continuing Operations		 358 11 135 56 69 75 11 153 93 11 50
Consolidated Net Income / (Loss)		 358 11 135 56 69 75 11 153 93 11 50
Depreciation Expense		 173 179 179 198 185 189 219 283 280 274 269
Amortization Expense		 -23 -24 -23 -26 -23 -25 -24 -22 -23 -21 -26
Non-Cash Adjustments to Reconcile Net Income		 -308 12 -81 -6.00 -5.44 -22 -52 -125 -61 29 3.69
Changes in Operating Assets and Liabilities, net		 44 30 -36 76 29 14 -1.75 27 29 -9.50 -17
Net Cash From Investing Activities		 -117 -298 56 -195 -222 -216 -98 188 30 -234 -231
Net Cash From Continuing Investing Activities		 -117 -298 56 -195 -222 -216 -98 188 30 -234 -231
Purchase of Property, Leasehold Improvements and Equipment		 -24 -33 -23 -19 -24 -47 -18 -36 -24 -39 -23
Purchase of Investment Securities		 -259 -281 -227 -216 -214 -199 -140 -139 -205 -109 -280
Sale and/or Maturity of Investments		 163 12 303 38 6.76 25 232 354 254 -89 65
Other Investing Activities, net		 3.25 3.77 3.21 3.21 8.56 5.66 -172 8.47 4.44 2.71 7.48
Net Cash From Financing Activities		 -93 49 -240 -60 -77 40 -67 -502 -266 -107 -94
Net Cash From Continuing Financing Activities		 -93 49 -240 -60 -77 40 -67 -502 -266 -107 -94
Issuance of Debt		 3,979 4,161 3,772 2,986 1,785 2,546 3,250 646 0.25 595 4,773
Issuance of Common Equity		 0.05 308 -0.15 -0.15 0.04 0.54 0.09 0.08 0.07 0.08 0.06
Repayment of Debt		 -3,847 -4,252 -3,817 -2,873 -1,691 -2,336 -3,043 -805 -26 -483 -4,619
Repurchase of Common Equity		 -56 -0.20 -6.47 -0.01 -0.01 -0.04 -102 -68 -20 -0.33 -25
Payment of Dividends		 -162 -161 -165 -164 -164 -164 -164 -211 -210 -210 -213
Other Financing Activities, Net		 -7.11 -6.78 -23 -8.20 -7.14 -6.74 -7.25 -63 -9.72 -9.34 -10

Annual Balance Sheets for Healthpeak Properties

This table presents Healthpeak Properties' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 21,450 15,759 14,088 12,719 14,033 15,920 15,258 15,771 15,699 19,938
Cash and Due from Banks		 340 95 55 111 80 44 158 72 118 120
Restricted Cash		 46 42 27 29 13 67 53 55 51 64
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 11,854 11,326 10,732 10,209 8,231 11,120 12,667 13,023 13,028 15,831
Intangible Assets		 587 480 410 305 260 520 520 418 314 817
Other Assets		 8,622 3,009 2,864 2,001 5,448 3,974 1,859 2,203 2,187 3,105
Total Liabilities & Shareholders' Equity		 21,450 15,759 14,088 12,719 14,033 15,920 15,258 15,771 15,699 19,938
Total Liabilities		 11,704 9,818 8,494 6,206 7,365 8,573 8,111 8,483 8,774 10,881
Short-Term Debt		 94 92 94 91 93 - 1,166 996 720 150
Other Short-Term Payables		 431 417 402 392 - 761 - - 657 725
Long-Term Debt		 10,975 9,097 7,786 5,477 5,909 6,298 5,004 5,502 6,156 8,566
Other Long-Term Liabilities		 204 211 211 246 1,363 1,514 1,941 1,985 1,240 1,439
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 - - - - - 57 87 106 49 2.61
Total Equity & Noncontrolling Interests		 9,746 5,941 5,595 6,513 6,667 7,290 7,059 7,183 6,876 9,055
Total Preferred & Common Equity		 9,344 5,548 5,301 5,944 6,085 6,734 6,515 6,655 6,350 8,401
Total Common Equity		 9,344 5,548 5,301 5,944 6,085 6,734 6,515 6,655 6,350 8,401
Common Stock		 12,113 8,667 8,696 8,876 9,689 10,714 10,639 10,896 10,953 13,547
Accumulated Other Comprehensive Income / (Loss)		 -30 -30 -24 -4.71 -2.86 -3.69 -3.15 28 19 29
Other Equity Adjustments		 - - - -2,927 - - - - -4,622 -5,174
Noncontrolling Interest		 403 394 294 568 582 556 543 528 526 654

Quarterly Balance Sheets for Healthpeak Properties

This table presents Healthpeak Properties' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Total Assets		 15,662 15,771 15,602 15,604 15,603 15,699 20,542 20,180 19,970 19,938 19,816
Cash and Due from Banks		 112 72 59 104 63 118 102 107 180 120 71
Restricted Cash		 55 55 58 57 50 51 55 52 62 64 68
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 12,878 13,023 13,087 13,097 13,120 13,028 16,663 16,398 15,892 15,831 15,840
Intangible Assets		 444 418 392 364 339 314 1,160 1,076 898 817 748
Other Assets		 2,173 2,203 2,006 1,981 2,029 2,187 2,561 2,546 2,937 3,105 3,090
Total Liabilities & Shareholders' Equity		 15,662 15,771 15,602 15,604 15,603 15,699 20,542 20,180 19,970 19,938 19,816
Total Liabilities		 8,536 8,483 8,379 8,478 8,570 8,774 10,943 10,761 10,748 10,881 10,972
Short-Term Debt		 - 996 556 329 424 720 183 25 0.00 150 164
Other Short-Term Payables		 733 - - - - 657 - - - 725 670
Long-Term Debt		 6,591 5,502 5,898 6,240 6,240 6,156 8,573 8,578 8,583 8,566 8,713
Other Long-Term Liabilities		 1,212 1,985 1,925 1,909 1,905 1,240 2,187 2,158 2,164 1,439 1,425
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 128 106 86 64 49 49 55 1.43 1.32 2.61 14
Total Equity & Noncontrolling Interests		 6,999 7,183 7,138 7,062 6,984 6,876 9,545 9,417 9,221 9,055 8,829
Total Preferred & Common Equity		 6,467 6,655 6,610 6,535 6,457 6,350 8,882 8,757 8,563 8,401 8,188
Total Common Equity		 6,467 6,655 6,610 6,535 6,457 6,350 8,882 8,757 8,563 8,401 8,188
Common Stock		 10,552 10,896 10,907 10,932 10,949 10,953 13,623 13,560 13,544 13,547 13,526
Retained Earnings		 -4,115 -4,270 - - - - -4,780 - - - -5,345
Accumulated Other Comprehensive Income / (Loss)		 30 28 19 31 37 19 39 42 -12 29 6.93
Noncontrolling Interest		 532 528 528 527 527 526 663 660 658 654 641

Annual Metrics and Ratios for Healthpeak Properties

This table displays calculated financial ratios and metrics derived from Healthpeak Properties' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 22.04% 13.96% -7.46% -39.63% 9.97% 39.48% 21.85% 8.63% 4.90% 22.18%
EBITDA Growth		 -12.90% 29.98% -25.31% -4.12% 23.41% -24.25% 34.86% 4.50% 10.63% 14.53%
EBIT Growth		 -56.59% 115.46% -68.74% -50.44% 83.56% -192.51% 344.16% 9.18% 29.04% -84.15%
NOPAT Growth		 -53.55% 98.55% -68.25% -50.34% 88.28% -193.61% 339.98% 7.41% 31.83% -84.87%
Net Income Growth		 -158.34% 217.11% -33.96% 154.00% -94.41% 613.03% 22.81% -1.81% -35.18% -20.15%
EPS Growth		 -158.34% 210.74% -34.33% 154.55% -95.98% 755.56% 20.78% -1.08% -39.13% -35.71%
Operating Cash Flow Growth		 -2.12% -0.66% -30.23% 0.20% -0.31% -10.36% 4.85% 13.21% 6.22% 11.95%
Free Cash Flow Firm Growth		 102.89% 23,686.22% -70.77% -17.27% -136.11% -101.55% 147.04% -160.44% 171.89% -1,947.45%
Invested Capital Growth		 0.47% -27.31% -10.94% -10.35% 4.88% 7.70% -2.41% 3.53% 0.11% 28.78%
Revenue Q/Q Growth		 6.07% 42.21% -4.07% -45.70% 15.31% 84.44% 4.14% 1.53% 1.32% 5.52%
EBITDA Q/Q Growth		 445.54% -2.68% -20.04% -5.75% 45.38% -19.01% 7.31% -1.67% 6.78% 6.58%
EBIT Q/Q Growth		 129.40% -10.10% -65.49% -44.10% 168.54% -821.84% 25.11% -7.10% 26.48% -43.95%
NOPAT Q/Q Growth		 145.02% -11.65% -66.10% -44.47% 170.60% -851.75% 23.31% -7.29% 31.12% -43.75%
Net Income Q/Q Growth		 -320.48% 4,101.79% -22.00% 492.53% -92.91% 31.62% -18.28% -4.05% 23.91% -19.49%
EPS Q/Q Growth		 -320.48% 2,014.29% -22.12% 522.22% -94.67% 30.51% -18.42% -4.17% 27.27% -23.40%
Operating Cash Flow Q/Q Growth		 -0.90% -10.27% -0.74% 0.79% 0.20% 0.16% 0.66% -1.85% 2.61% 5.13%
Free Cash Flow Firm Q/Q Growth		 101.53% 328.45% -76.60% 50.77% 34.25% -59.58% -52.84% 54.64% 9.71% 2.69%
Invested Capital Q/Q Growth		 -3.66% -26.18% 1.16% -2.88% -3.46% -1.02% 3.41% 0.50% 0.76% -0.18%
Profitability Metrics		 - - - - - - - - - -
EBITDA Margin		 44.13% 50.33% 40.62% 64.52% 72.41% 39.32% 43.52% 41.86% 44.15% 41.39%
EBIT Margin		 7.78% 14.71% 4.97% 4.08% 6.81% -4.52% 9.05% 9.10% 11.19% 1.45%
Profit (Net Income) Margin		 -37.40% 38.44% 27.43% 115.42% 5.87% 30.02% 30.26% 27.35% 16.90% 11.05%
Tax Burden Percent		 -400.98% 174.23% 102.98% 128.01% 34.06% 196.73% 409.71% 101.83% 106.29% 97.85%
Interest Burden Percent		 119.87% 149.94% 536.01% 2,209.92% 253.13% -337.81% 81.59% 295.21% 142.08% 777.64%
Effective Tax Rate		 -7.20% 1.22% -0.32% -0.52% -3.11% -4.33% -2.54% -0.87% -3.05% 1.59%
Return on Invested Capital (ROIC)		 0.59% 1.35% 0.54% 0.30% 0.58% -0.51% 1.20% 1.28% 1.66% 0.22%
ROIC Less NNEP Spread (ROIC-NNEP)		 -5.84% 5.28% 4.59% 15.70% 0.38% 7.55% 7.05% 6.70% 3.25% 3.20%
Return on Net Nonoperating Assets (RNNOA)		 -5.86% 6.81% 6.79% 17.43% 0.33% 6.62% 6.06% 5.88% 3.05% 3.13%
Return on Equity (ROE)		 -5.27% 8.16% 7.33% 17.73% 0.91% 6.11% 7.26% 7.16% 4.71% 3.34%
Cash Return on Invested Capital (CROIC)		 0.12% 32.97% 12.11% 11.22% -4.18% -7.93% 3.64% -2.19% 1.55% -24.94%
Operating Return on Assets (OROA)		 0.53% 1.32% 0.51% 0.28% 0.52% -0.43% 1.01% 1.11% 1.41% 0.20%
Return on Assets (ROA)		 -2.55% 3.44% 2.83% 8.01% 0.45% 2.86% 3.37% 3.33% 2.13% 1.50%
Return on Common Equity (ROCE)		 -5.10% 7.74% 6.89% 16.47% 0.83% 5.59% 6.63% 6.53% 4.31% 3.09%
Return on Equity Simple (ROE_SIMPLE)		 -5.85% 11.54% 7.97% 18.06% 0.99% 6.36% 8.07% 7.76% 5.27% 3.18%
Net Operating Profit after Tax (NOPAT)		 122 242 77 38 72 -67 161 173 228 35
NOPAT Margin		 8.34% 14.53% 4.99% 4.10% 7.02% -4.71% 9.28% 9.18% 11.53% 1.43%
Net Nonoperating Expense Percent (NNEP)		 6.43% -3.93% -4.05% -15.40% 0.20% -8.06% -5.85% -5.42% -1.59% -2.99%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 92.22% 85.29% 95.03% 95.92% 93.19% 104.52% 90.95% 90.90% 88.81% 98.55%
Earnings before Interest and Taxes (EBIT)		 114 245 77 38 70 -64 157 172 222 35
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 645 838 626 600 741 561 756 790 874 1,002
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 1.18 1.80 1.60 1.62 2.16 1.96 2.51 1.77 1.58 1.66
Price to Tangible Book Value (P/TBV)		 1.26 1.98 1.73 1.71 2.25 2.12 2.72 1.89 1.66 1.84
Price to Revenue (P/Rev)		 7.55 6.01 5.50 10.37 12.83 9.24 9.39 6.25 5.07 5.77
Price to Earnings (P/E)		 0.00 15.98 20.51 9.11 298.30 32.05 32.50 23.70 32.99 57.60
Dividend Yield		 9.53% 9.96% 8.20% 7.21% 5.58% 6.05% 3.96% 5.47% 6.54% 6.01%
Earnings Yield		 0.00% 6.26% 4.88% 10.97% 0.34% 3.12% 3.08% 4.22% 3.03% 1.74%
Enterprise Value to Invested Capital (EV/IC)		 1.06 1.29 1.23 1.29 1.55 1.46 1.72 1.36 1.25 1.30
Enterprise Value to Revenue (EV/Rev)		 15.14 11.69 10.75 16.82 19.18 14.00 13.18 9.96 8.74 9.57
Enterprise Value to EBITDA (EV/EBITDA)		 34.30 23.22 26.46 26.07 26.48 35.61 30.29 23.79 19.80 23.11
Enterprise Value to EBIT (EV/EBIT)		 194.53 79.43 216.31 412.22 281.56 0.00 145.64 109.45 78.13 659.00
Enterprise Value to NOPAT (EV/NOPAT)		 181.47 80.41 215.61 410.07 273.08 0.00 142.03 108.50 75.82 669.66
Enterprise Value to Operating Cash Flow (EV/OCF)		 18.10 16.03 19.55 18.43 23.18 26.34 28.81 20.89 18.11 21.62
Enterprise Value to Free Cash Flow (EV/FCFF)		 887.61 3.28 9.56 10.92 0.00 0.00 46.71 0.00 81.25 0.00
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 1.14 1.55 1.41 0.85 0.90 0.86 0.86 0.89 0.99 0.96
Long-Term Debt to Equity		 1.13 1.53 1.39 0.84 0.89 0.86 0.70 0.75 0.89 0.95
Financial Leverage		 1.00 1.29 1.48 1.11 0.88 0.88 0.86 0.88 0.94 0.98
Leverage Ratio		 2.06 2.37 2.59 2.21 2.03 2.14 2.15 2.15 2.21 2.23
Compound Leverage Factor		 2.47 3.56 13.87 48.93 5.14 -7.22 1.76 6.35 3.15 17.34
Debt to Total Capital		 53.18% 60.73% 58.48% 46.09% 47.37% 46.15% 46.33% 47.13% 49.82% 49.04%
Short-Term Debt to Total Capital		 0.45% 0.61% 0.70% 0.75% 0.73% 0.00% 8.76% 7.22% 5.22% 0.84%
Long-Term Debt to Total Capital		 52.72% 60.12% 57.78% 45.34% 46.64% 46.15% 37.58% 39.91% 44.61% 48.20%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 1.93% 2.60% 2.18% 4.70% 4.60% 4.50% 4.74% 4.60% 4.16% 3.69%
Common Equity to Total Capital		 44.89% 36.66% 39.34% 49.21% 48.03% 49.35% 48.93% 48.27% 46.01% 47.27%
Debt to EBITDA		 17.17 10.97 12.59 9.28 8.11 11.23 8.16 8.22 7.86 8.70
Net Debt to EBITDA		 16.57 10.80 12.46 9.05 7.98 11.03 7.88 8.06 7.67 8.52
Long-Term Debt to EBITDA		 17.02 10.86 12.44 9.13 7.98 11.23 6.61 6.96 7.04 8.55
Debt to NOPAT		 90.83 37.98 102.59 145.97 83.57 -93.68 38.24 37.50 30.10 252.14
Net Debt to NOPAT		 87.66 37.41 101.52 142.30 82.27 -92.02 36.93 36.77 29.36 246.81
Long-Term Debt to NOPAT		 90.05 37.60 101.36 143.59 82.28 -93.68 31.02 31.75 26.95 247.80
Noncontrolling Interest Sharing Ratio		 3.20% 5.08% 5.96% 7.12% 8.73% 8.53% 8.59% 8.76% 8.50% 7.70%
Liquidity Ratios		 - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 25 5,926 1,732 1,433 -517 -1,043 491 -297 213 -3,938
Operating Cash Flow to CapEx		 10,977.68% 0.00% 734.90% 799.21% 777.33% 805.80% 713.35% 829.66% 841.79% 924.56%
Free Cash Flow to Firm to Interest Expense		 0.05 12.76 5.63 5.48 -2.38 -4.78 3.11 -1.71 1.06 -14.04
Operating Cash Flow to Interest Expense		 2.55 2.61 2.75 3.25 3.89 3.47 5.03 5.21 4.77 3.82
Operating Cash Flow Less CapEx to Interest Expense		 2.53 3.81 2.38 2.84 3.39 3.04 4.33 4.58 4.21 3.40
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.07 0.09 0.10 0.07 0.08 0.10 0.11 0.12 0.13 0.14
Fixed Asset Turnover		 0.13 0.14 0.14 0.09 0.11 0.15 0.15 0.15 0.15 0.17
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 20,815 15,131 13,475 12,080 12,670 13,645 13,316 13,786 13,801 17,774
Invested Capital Turnover		 0.07 0.09 0.11 0.07 0.08 0.11 0.13 0.14 0.14 0.15
Increase / (Decrease) in Invested Capital		 97 -5,685 -1,655 -1,395 589 976 -329 470 15 3,973
Enterprise Value (EV)		 22,115 19,456 16,562 15,642 19,612 19,976 22,914 18,802 17,319 23,149
Market Capitalization		 11,030 10,010 8,470 9,646 13,121 13,176 16,325 11,798 10,037 13,961
Book Value per Share		 $20.09 $11.85 $11.30 $12.65 $12.29 $12.51 $12.09 $12.38 $11.61 $12.01
Tangible Book Value per Share		 $18.83 $10.83 $10.43 $12.00 $11.77 $11.54 $11.12 $11.60 $11.03 $10.84
Total Capital		 20,815 15,131 13,475 12,080 12,670 13,645 13,316 13,786 13,801 17,774
Total Debt		 11,069 9,189 7,880 5,568 6,002 6,298 6,170 6,498 6,876 8,716
Total Long-Term Debt		 10,975 9,097 7,786 5,477 5,909 6,298 5,004 5,502 6,156 8,566
Net Debt		 10,682 9,053 7,798 5,428 5,908 6,187 5,958 6,371 6,707 8,532
Capital Expenditures (CapEx)		 11 -556 115 106 109 94 111 109 114 116
Net Nonoperating Expense (NNE)		 668 -398 -346 -1,035 12 -495 -365 -343 -106 -233
Net Nonoperating Obligations (NNO)		 11,069 9,189 7,880 5,568 6,002 6,298 6,170 6,498 6,876 8,716
Total Depreciation and Amortization (D&A)		 531 593 549 562 671 625 599 619 653 966
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($1.11) $1.34 $0.88 $2.25 $0.09 $0.77 $0.93 $0.92 $0.56 $0.36
Adjusted Weighted Average Basic Shares Outstanding		 506.09M 467.20M 468.76M 470.55M 486.26M 530.56M 538.93M 538.81M 547.01M 675.68M
Adjusted Diluted Earnings per Share		 ($1.11) $1.34 $0.88 $2.24 $0.09 $0.77 $0.93 $0.92 $0.56 $0.36
Adjusted Weighted Average Diluted Shares Outstanding		 506.09M 467.40M 468.94M 475.39M 489.34M 531.06M 539.24M 539.15M 547.28M 676.23M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.09 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 509.08M 468.18M 469.44M 477.77M 505.41M 538.69M 539.30M 546.78M 547.17M 699.56M
Normalized Net Operating Profit after Tax (NOPAT)		 175 252 176 35 63 -2.23 128 129 164 188
Normalized NOPAT Margin		 11.95% 15.12% 11.40% 3.76% 6.11% -0.16% 7.34% 6.81% 8.26% 7.76%
Pre Tax Income Margin		 9.33% 22.06% 26.64% 90.17% 17.24% 15.26% 7.39% 26.86% 15.90% 11.29%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 0.24 0.53 0.25 0.15 0.32 -0.30 1.00 0.99 1.11 0.13
NOPAT to Interest Expense		 0.25 0.52 0.25 0.15 0.33 -0.31 1.02 1.00 1.14 0.12
EBIT Less CapEx to Interest Expense		 0.21 1.73 -0.13 -0.26 -0.18 -0.73 0.29 0.37 0.54 -0.29
NOPAT Less CapEx to Interest Expense		 0.23 1.72 -0.12 -0.26 -0.17 -0.74 0.32 0.37 0.57 -0.29
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 -191.55% 153.07% 164.43% 64.92% 1,198.99% 183.79% 123.61% 125.49% 196.27% 297.33%
Augmented Payout Ratio		 -193.14% 154.43% 165.57% 65.24% 1,207.38% 186.25% 126.05% 138.62% 198.22% 368.67%

Quarterly Metrics and Ratios for Healthpeak Properties

This table displays calculated financial ratios and metrics derived from Healthpeak Properties' official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 6.91% 6.36% 3.67% 4.26% 6.17% 5.43% 14.22% 25.03% 23.84% 25.28% 15.49%
EBITDA Growth		 2.69% -7.49% -0.12% 2.92% 10.99% 33.49% -34.52% 32.68% 28.67% 27.92% 123.25%
EBIT Growth		 27.07% -54.44% -1.75% -13.15% 21.41% 422.20% -217.04% -38.57% -46.55% -47.99% 201.93%
NOPAT Growth		 27.02% -54.61% -0.93% -15.85% 18.71% 484.97% -145.89% -38.36% -46.98% -69.59% 350.60%
Net Income Growth		 478.27% -66.84% 78.53% -22.26% -80.82% 597.97% -91.69% 171.74% 35.08% -85.85% 347.92%
EPS Growth		 550.00% -80.00% 69.23% -30.77% -81.54% 1,200.00% -95.45% 133.33% 0.00% -84.62% 500.00%
Operating Cash Flow Growth		 15.06% -7.57% -10.43% 16.57% 3.95% 11.74% -12.28% 6.17% 25.64% 22.61% 83.16%
Free Cash Flow Firm Growth		 -182.48% -228.99% 1.86% 73.08% 110.84% 111.67% -1,812.59% -1,709.83% -4,882.92% -7,493.81% 114.75%
Invested Capital Growth		 6.53% 3.53% 2.21% 2.12% -0.15% 0.11% 34.20% 31.60% 29.99% 28.78% -3.46%
Revenue Q/Q Growth		 0.06% -0.27% 0.56% 3.90% 1.89% -0.96% 8.94% 13.73% 0.92% 0.19% 0.43%
EBITDA Q/Q Growth		 -3.90% -18.92% 24.81% 5.83% 3.63% -2.48% -38.78% 114.45% 0.50% -3.05% 6.84%
EBIT Q/Q Growth		 -1.37% -79.74% 360.77% -5.68% 37.88% -12.85% -203.27% 149.51% 19.96% -15.20% 102.39%
NOPAT Q/Q Growth		 -1.35% -78.57% 330.09% -7.43% 39.17% 5.58% -133.74% 224.34% 19.70% -39.45% 178.05%
Net Income Q/Q Growth		 395.19% -96.98% 1,145.20% -58.22% 22.17% 9.82% -85.18% 1,266.34% -39.27% -88.49% 369.12%
EPS Q/Q Growth		 400.00% -98.46% 2,100.00% -59.09% 33.33% 8.33% -92.31% 2,000.00% -42.86% -83.33% 200.00%
Operating Cash Flow Q/Q Growth		 -4.64% -15.06% -15.96% 71.24% -14.96% -8.69% -34.03% 107.26% 0.63% -10.90% -1.45%
Free Cash Flow Firm Q/Q Growth		 10.95% 41.70% 46.34% 3.37% 135.86% -37.25% -8,895.93% 8.56% 5.24% 3.00% 117.55%
Invested Capital Q/Q Growth		 2.29% 0.50% -0.79% 0.12% 0.02% 0.76% 33.00% -1.82% -1.20% -0.18% -0.30%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 42.94% 34.91% 43.33% 44.14% 44.89% 44.20% 24.84% 46.84% 46.64% 45.14% 48.02%
EBIT Margin		 11.39% 2.31% 10.60% 9.62% 13.02% 11.46% -10.86% 4.73% 5.62% 4.76% 9.59%
Profit (Net Income) Margin		 75.16% 2.27% 28.16% 11.32% 13.58% 15.05% 2.05% 24.61% 14.81% 1.70% 7.94%
Tax Burden Percent		 100.62% 114.49% 101.14% 102.92% 101.95% 125.67% 49.68% 98.28% 94.14% -329.99% 92.21%
Interest Burden Percent		 655.85% 85.84% 262.61% 114.32% 102.25% 104.53% -37.96% 529.54% 279.83% -10.83% 89.86%
Effective Tax Rate		 -1.08% -6.89% 0.23% 2.08% 1.17% -19.74% 60.88% 1.76% 1.97% 0.00% 3.83%
Return on Invested Capital (ROIC)		 1.61% 0.34% 1.49% 1.34% 1.84% 1.97% -0.54% 0.64% 0.80% 0.51% 1.28%
ROIC Less NNEP Spread (ROIC-NNEP)		 6.61% 0.33% 2.80% 1.48% 1.89% 2.07% -0.09% 2.27% 1.57% 0.38% 1.19%
Return on Net Nonoperating Assets (RNNOA)		 5.54% 0.29% 2.51% 1.37% 1.77% 1.95% -0.08% 2.08% 1.47% 0.37% 1.14%
Return on Equity (ROE)		 7.15% 0.63% 4.00% 2.71% 3.60% 3.92% -0.63% 2.72% 2.27% 0.88% 2.42%
Cash Return on Invested Capital (CROIC)		 -4.92% -2.19% -0.92% -0.88% 1.42% 1.55% -28.52% -26.71% -25.69% -24.94% 4.40%
Operating Return on Assets (OROA)		 1.39% 0.28% 1.31% 1.20% 1.63% 1.44% -1.23% 0.57% 0.72% 0.65% 1.19%
Return on Assets (ROA)		 9.19% 0.28% 3.47% 1.41% 1.70% 1.89% 0.23% 2.99% 1.91% 0.23% 0.99%
Return on Common Equity (ROCE)		 6.50% 0.58% 3.65% 2.47% 3.29% 3.59% -0.58% 2.51% 2.10% 0.81% 2.24%
Return on Equity Simple (ROE_SIMPLE)		 8.32% 0.00% 8.71% 8.56% 4.18% 0.00% 2.38% 3.52% 3.88% 0.00% 3.74%
Net Operating Profit after Tax (NOPAT)		 55 12 51 47 65 69 -23 29 35 21 58
NOPAT Margin		 11.51% 2.47% 10.58% 9.42% 12.87% 13.72% -4.25% 4.65% 5.51% 3.33% 9.22%
Net Nonoperating Expense Percent (NNEP)		 -5.00% 0.01% -1.31% -0.14% -0.05% -0.10% -0.45% -1.63% -0.76% 0.13% 0.09%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 88.61% 97.69% 89.40% 90.38% 86.98% 88.54% 110.86% 95.27% 94.38% 95.24% 90.41%
Earnings before Interest and Taxes (EBIT)		 54 11 51 48 66 57 -59 29 35 30 60
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 205 166 207 219 227 221 136 291 292 283 303
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.65 1.77 1.61 1.51 1.42 1.58 1.09 1.51 1.81 1.66 1.72
Price to Tangible Book Value (P/TBV)		 1.78 1.89 1.71 1.60 1.49 1.66 1.25 1.72 2.03 1.84 1.89
Price to Revenue (P/Rev)		 5.75 6.25 5.58 5.13 4.68 5.07 4.72 6.08 6.77 5.77 5.62
Price to Earnings (P/E)		 20.58 23.70 19.48 18.64 38.07 32.99 50.09 46.01 50.31 57.60 50.55
Dividend Yield		 6.06% 5.47% 6.17% 6.65% 7.18% 6.54% 6.79% 6.39% 5.40% 6.01% 5.99%
Earnings Yield		 4.86% 4.22% 5.13% 5.36% 2.63% 3.03% 2.00% 2.17% 1.99% 1.74% 1.98%
Enterprise Value to Invested Capital (EV/IC)		 1.30 1.36 1.29 1.23 1.19 1.25 1.03 1.24 1.38 1.30 1.32
Enterprise Value to Revenue (EV/Rev)		 9.56 9.96 9.23 8.76 8.32 8.74 9.27 10.27 10.70 9.57 9.37
Enterprise Value to EBITDA (EV/EBITDA)		 22.11 23.79 22.25 21.18 19.87 19.80 23.64 25.51 26.11 23.11 20.08
Enterprise Value to EBIT (EV/EBIT)		 96.12 109.45 102.90 103.09 92.84 78.13 169.91 239.11 391.47 659.00 151.54
Enterprise Value to NOPAT (EV/NOPAT)		 95.10 108.50 102.02 102.52 93.39 75.82 173.11 243.40 399.21 669.66 148.01
Enterprise Value to Operating Cash Flow (EV/OCF)		 19.38 20.89 19.98 18.29 17.46 18.11 20.31 23.41 24.10 21.62 19.59
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 83.74 81.25 0.00 0.00 0.00 0.00 29.56
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.92 0.89 0.89 0.92 0.95 0.99 0.91 0.91 0.93 0.96 1.00
Long-Term Debt to Equity		 0.92 0.75 0.82 0.88 0.89 0.89 0.89 0.91 0.93 0.95 0.99
Financial Leverage		 0.84 0.88 0.90 0.92 0.94 0.94 0.90 0.92 0.94 0.98 0.96
Leverage Ratio		 2.10 2.15 2.16 2.20 2.21 2.21 2.15 2.16 2.19 2.23 2.19
Compound Leverage Factor		 13.79 1.85 5.68 2.51 2.26 2.31 -0.82 11.45 6.12 -0.24 1.97
Debt to Total Capital		 48.05% 47.13% 47.19% 47.97% 48.66% 49.82% 47.70% 47.74% 48.21% 49.04% 50.09%
Short-Term Debt to Total Capital		 0.00% 7.22% 4.07% 2.40% 3.10% 5.22% 1.00% 0.14% 0.00% 0.84% 0.93%
Long-Term Debt to Total Capital		 48.05% 39.91% 43.12% 45.56% 45.56% 44.61% 46.70% 47.60% 48.21% 48.20% 49.17%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 4.81% 4.60% 4.49% 4.31% 4.20% 4.16% 3.91% 3.67% 3.70% 3.69% 3.70%
Common Equity to Total Capital		 47.14% 48.27% 48.33% 47.72% 47.14% 46.01% 48.39% 48.59% 48.09% 47.27% 46.21%
Debt to EBITDA		 8.20 8.22 8.17 8.25 8.14 7.86 10.90 9.84 9.13 8.70 7.60
Net Debt to EBITDA		 7.99 8.06 8.02 8.05 8.00 7.67 10.71 9.65 8.88 8.52 7.48
Long-Term Debt to EBITDA		 8.20 6.96 7.46 7.83 7.62 7.04 10.68 9.81 9.13 8.55 7.46
Debt to NOPAT		 35.26 37.50 37.44 39.92 38.25 30.10 79.83 93.83 139.67 252.14 56.00
Net Debt to NOPAT		 34.37 36.77 36.76 38.94 37.60 29.36 78.39 92.09 135.73 246.81 55.13
Long-Term Debt to NOPAT		 35.26 31.75 34.22 37.92 35.82 26.95 78.16 93.56 139.67 247.80 54.97
Noncontrolling Interest Sharing Ratio		 9.18% 8.76% 8.77% 8.82% 8.72% 8.50% 7.92% 7.57% 7.60% 7.70% 7.45%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -786 -458 -246 -238 85 53 -4,701 -4,299 -4,074 -3,952 693
Operating Cash Flow to CapEx		 1,000.24% 619.50% 763.18% 1,531.66% 1,053.88% 488.57% 870.95% 885.27% 1,353.53% 726.26% 1,207.77%
Free Cash Flow to Firm to Interest Expense		 -17.83 -9.27 -5.12 -4.84 1.69 1.01 -77.18 -57.38 -54.97 -56.04 9.54
Operating Cash Flow to Interest Expense		 5.53 4.19 3.63 6.07 5.01 4.38 2.50 4.22 4.29 4.02 3.84
Operating Cash Flow Less CapEx to Interest Expense		 4.97 3.51 3.15 5.67 4.54 3.48 2.22 3.74 3.98 3.47 3.53
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.12 0.12 0.12 0.12 0.13 0.13 0.11 0.12 0.13 0.14 0.12
Fixed Asset Turnover		 0.15 0.15 0.15 0.15 0.15 0.15 0.14 0.15 0.16 0.17 0.15
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 13,717 13,786 13,678 13,694 13,697 13,801 18,355 18,022 17,805 17,774 17,720
Invested Capital Turnover		 0.14 0.14 0.14 0.14 0.14 0.14 0.13 0.14 0.15 0.15 0.14
Increase / (Decrease) in Invested Capital		 841 470 296 284 -20 15 4,678 4,327 4,108 3,973 -635
Enterprise Value (EV)		 17,775 18,802 17,584 16,870 16,271 17,319 18,987 22,316 24,534 23,149 23,461
Market Capitalization		 10,691 11,798 10,634 9,871 9,145 10,037 9,671 13,211 15,534 13,961 14,068
Book Value per Share		 $11.99 $12.38 $12.09 $11.95 $11.80 $11.61 $14.78 $12.44 $12.25 $12.01 $11.70
Tangible Book Value per Share		 $11.16 $11.60 $11.37 $11.28 $11.18 $11.03 $12.85 $10.91 $10.96 $10.84 $10.64
Total Capital		 13,717 13,786 13,678 13,694 13,697 13,801 18,355 18,022 17,805 17,774 17,720
Total Debt		 6,591 6,498 6,454 6,569 6,664 6,876 8,756 8,603 8,583 8,716 8,877
Total Long-Term Debt		 6,591 5,502 5,898 6,240 6,240 6,156 8,573 8,578 8,583 8,566 8,713
Net Debt		 6,424 6,371 6,337 6,408 6,550 6,707 8,599 8,444 8,341 8,532 8,738
Capital Expenditures (CapEx)		 24 33 23 19 24 47 18 36 24 39 23
Net Nonoperating Expense (NNE)		 -303 0.95 -84 -9.43 -3.56 -6.67 -34 -124 -58 10 8.04
Net Nonoperating Obligations (NNO)		 6,591 6,498 6,454 6,569 6,664 6,876 8,756 8,603 8,583 8,716 8,877
Total Depreciation and Amortization (D&A)		 150 155 156 171 161 164 195 261 257 253 242
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.66 $0.00 $0.22 $0.09 $0.12 $0.13 $0.01 $0.21 $0.12 $0.02 $0.06
Adjusted Weighted Average Basic Shares Outstanding		 538.42M 538.81M 546.84M 547.03M 547.06M 547.01M 600.90M 702.38M 699.35M 675.68M 699.07M
Adjusted Diluted Earnings per Share		 $0.65 $0.01 $0.22 $0.09 $0.12 $0.13 $0.01 $0.21 $0.12 $0.02 $0.06
Adjusted Weighted Average Diluted Shares Outstanding		 546.02M 539.15M 547.11M 547.29M 547.33M 547.28M 601.19M 703.27M 700.15M 676.23M 699.12M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 537.54M 546.78M 547.00M 547.05M 547.07M 547.17M 703.78M 699.29M 699.44M 699.56M 694.73M
Normalized Net Operating Profit after Tax (NOPAT)		 41 12 51 50 65 46 42 36 42 36 60
Normalized NOPAT Margin		 8.58% 2.58% 10.62% 10.06% 12.77% 9.28% 7.62% 5.79% 6.70% 5.81% 9.52%
Pre Tax Income Margin		 74.69% 1.99% 27.84% 11.00% 13.32% 11.98% 4.12% 25.04% 15.73% -0.52% 8.61%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 1.23 0.22 1.06 0.97 1.30 1.09 -0.97 0.39 0.48 0.42 0.83
NOPAT to Interest Expense		 1.24 0.24 1.05 0.95 1.29 1.30 -0.38 0.38 0.47 0.30 0.80
EBIT Less CapEx to Interest Expense		 0.68 -0.45 0.58 0.58 0.83 0.19 -1.26 -0.09 0.16 -0.13 0.51
NOPAT Less CapEx to Interest Expense		 0.69 -0.44 0.58 0.56 0.81 0.41 -0.67 -0.09 0.15 -0.26 0.48
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 120.58% 125.49% 112.85% 116.48% 242.08% 196.27% 310.39% 228.36% 225.60% 297.33% 275.67%
Augmented Payout Ratio		 133.20% 138.62% 123.79% 127.69% 244.56% 198.22% 358.66% 283.66% 282.94% 368.67% 312.78%

Frequently Asked Questions About Healthpeak Properties' Financials

When does Healthpeak Properties's fiscal year end?

According to the most recent income statement we have on file, Healthpeak Properties' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Healthpeak Properties' net income changed over the last 9 years?

Healthpeak Properties' net income appears to be on an upward trend, with a most recent value of $267.30 million in 2024, falling from -$546.42 million in 2015. The previous period was $334.76 million in 2023. See Healthpeak Properties' forecast for analyst expectations on what’s next for the company.

How has Healthpeak Properties revenue changed over the last 9 years?

Over the last 9 years, Healthpeak Properties' total revenue changed from $1.46 billion in 2015 to $2.42 billion in 2024, a change of 65.7%.

How much debt does Healthpeak Properties have?

Healthpeak Properties' total liabilities were at $10.88 billion at the end of 2024, a 24.0% increase from 2023, and a 7.0% decrease since 2015.

How much cash does Healthpeak Properties have?

In the past 9 years, Healthpeak Properties' cash and equivalents has ranged from $44.23 million in 2020 to $340.44 million in 2015, and is currently $119.82 million as of their latest financial filing in 2024.

How has Healthpeak Properties' book value per share changed over the last 9 years?

Over the last 9 years, Healthpeak Properties' book value per share changed from 20.09 in 2015 to 12.01 in 2024, a change of -40.2%.


Related Companies

This page (NYSE:DOC) was last updated on 5/6/2025 by MarketBeat.com Staff
From Our Partners
3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...
Porter & Company | Sponsored
Trump Orders 'National Digital Asset Stockpile'
Trump's tariffs on China have caused a ripple effect across global markets. But in crypto? They've lit a fu...
Crypto 101 Media | Sponsored
REVEALED: Elon’s Secret Master Plan “AGENDA X”
REVEALED: Elon's Secret Master Plan "AGENDA X" For almost 30 years, Elon worked on his master plan in secre...
Brownstone Research | Sponsored
Why Elon put $51 million into this
Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists
True Market Insiders | Sponsored
This Is The Moment You Betray Trump (Or Prove Them Wrong)
They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...
Colonial Metals | Sponsored
URGENT: Someone's Moving Gold Out of London...
People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...
Golden Portfolio | Sponsored
Altucher: Turn $900 into $108,000 in just 12 months?
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
Paradigm Press | Sponsored